Please login to the form below

Not currently logged in
Email:
Password:

Anaveon

This page shows the latest Anaveon news and features for those working in and with pharma, biotech and healthcare.

Novartis and Syncona back new Swiss biotech Anaveon

Novartis and Syncona back new Swiss biotech Anaveon

Founders focused on IL-2 Receptor Agonists. Novartis' venture fund arm and Syncona are supporting new Switzerland-based immuno-oncology specialists Anaveon. ... re-direction of IL-2 activity in vivo, Anaveon has developed biologic approaches for the

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...